Overview

Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of escitalopram to an active comparator in severely depressed patients
Phase:
Phase 4
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Citalopram
Dexetimide